Immediate Impact
2 from Science/Nature 51 standout
Citing Papers
Pancreatic cancer
2025 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Melissa Dinolfo being referenced
Comparison of the pharmacokinetics and pharmacodynamics of S‐1 between Caucasian and East Asian patients
2010
A phase 1 dose-escalation study of XL518, a potent MEK inhibitor administered orally daily to subjects with solid tumors
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Melissa Dinolfo | 207 | 105 | 156 | 7 | 350 | |
| Tomohiro Funakoshi | 109 | 94 | 109 | 11 | 320 | |
| Brielan Smiechowski | 104 | 125 | 44 | 7 | 324 | |
| Jeffrey Lombardo | 164 | 42 | 108 | 11 | 326 | |
| Marco Carletto | 128 | 76 | 121 | 10 | 313 | |
| Katherine Seibert | 136 | 104 | 68 | 10 | 386 | |
| E. Paul | 171 | 64 | 62 | 10 | 370 | |
| Eva Regina Haspinger | 148 | 118 | 125 | 13 | 392 | |
| Jessica Lee Yarber | 293 | 51 | 184 | 6 | 379 | |
| Susan M. Flick | 130 | 109 | 69 | 6 | 358 | |
| Jieli Han | 160 | 96 | 70 | 8 | 355 |
All Works
Loading papers...